SCHEMBL6927442

SCHEMBL6927442

CCCN1CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL178388 1.00
Hydrochloric Acid SCHEMBL1578109 0.97 POLB (0.48)
Hydrochloric Acid SCHEMBL1318698 0.97 POLB (0.48)
Bromide SCHEMBL452246 0.97 POLB (0.48)
Ammonia Solution, Strong SCHEMBL238025 0.97 POLB (0.48)
SCHEMBL3971660 0.97 CXCR4 (0.52)
Methylamine SCHEMBL928302 0.95 POLB (0.46)
Bromide SCHEMBL11717124 0.95 POLB (0.46)
Hydrochloric Acid SCHEMBL28781885 0.95 POLB (0.46)
Dimethylamine SCHEMBL4062959 0.93 POLB (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355635-B1 IMIDAZOLEBENZENE, IMIDAZOLEPYRIDINE COMPOUNDS FOR TREATMENT OF OBESITY PFIZER INC. 2002-03-12 US claimed
US-20010039277-A1 Compounds for the treatment of obesity ELLIOTT RICHARD L (US) 2001-11-08 US claimed
WO-2000066578-A1 COMPOUNDS FOR THE TREATMENT OF OBESITY PFIZER PRODUCTS INC. (US) 2000-11-09 WO claimed
EP-1020447-A1 PYRAZOLE COMPOUNDS AND PLANT DISEASE CONTROL AGENT Nissan Chemical Industries, Ltd. (JP) 2000-07-19 EP claimed
US-RE33907-E Anti-spasmodic agents having a heterocyclic ring UNITED PHARMACEUTICALS, INC. (US) 1992-04-28 US claimed
US-4857535-A THIOESTERS UNITED PHARMACEUTICALS (US) 1989-08-15 US claimed
US-4721783-A SMOOTH MUSCLES UNITED PHARMACEUTICALS, INC. (US) 1988-01-26 US claimed
US-9150545-B2 Carboxamide compounds and their use as calpain inhibitors V AbbVie Deutschland GmbH & Co. KG (DE) 2015-10-06 US disclosed
US-20150065477-A1 CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS V AbbVie Deutschland GmbH & Co. KG (DE) 2015-03-05 US disclosed
US-6514966-B2 Neuropeptide Y antagonists such as 2-chloro-5-(4-(3,4-dich loro-phenyl)-1H-imidazol-2-yl)-pyridine PFIZER INC. 2003-02-04 US disclosed
US-6355635-B1 IMIDAZOLEBENZENE, IMIDAZOLEPYRIDINE COMPOUNDS FOR TREATMENT OF OBESITY PFIZER INC. 2002-03-12 US disclosed
US-20010039277-A1 Compounds for the treatment of obesity ELLIOTT RICHARD L (US) 2001-11-08 US disclosed
WO-2000066578-A1 COMPOUNDS FOR THE TREATMENT OF OBESITY PFIZER PRODUCTS INC. (US) 2000-11-09 WO disclosed
US-5387686-A Sublimable, yellow quinoline derivatives; storage stable; heat light, chemical resistant MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1995-02-07 US disclosed
US-5296445-A Quinoline dyes MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1994-03-22 US disclosed
EP-0527051-A1 Quinophthalone dyes, ink composition and transfer sheet containing them MITSUI TOATSU CHEMICALS, Inc. (JP) 1993-02-10 EP disclosed
US-RE33907-E Anti-spasmodic agents having a heterocyclic ring UNITED PHARMACEUTICALS, INC. (US) 1992-04-28 US disclosed
US-4857535-A THIOESTERS UNITED PHARMACEUTICALS (US) 1989-08-15 US disclosed
US-4721783-A SMOOTH MUSCLES UNITED PHARMACEUTICALS, INC. (US) 1988-01-26 US disclosed
US-4034094-A 8-Alkyl-5-oxo-5,8-dihydro-pyrido(2,3-d)pyrimidine-6-carboxylic acids for treating urinary tract infections LABORATOIRE ROGER BELLOW (FR) 1977-07-05 US disclosed